Surescreen Australia

SureScreen continues to focus on new and emerging variants of SARS-CoV-2 worldwide and closely tracks the mutant strains reported by WHO and GISAID.

Analysis of recent variants of concern including XBB, BQ.1 and BQ.1.1 indicates that the risk of the new variant(s) not being detected by the SureScreen SARS-CoV-2 Rapid Antigen Test is low.

Other variants tested and results infer to a large extent that the product is capable of detecting

B.1.617.2 (Delta), BA.1, BA.2, BA2.10, BA.2.12, BA.2.12.1, BA.4, BA.4.6 BA.5, BA.2.75, XE, BE.3, BF.7, BJ.1

SureScreen BBC East Midlands

PDF Link Checker

The Cost of Diagnostic Errors in Covid

PDF Link Checker

SureScreen Diagnostics and Guy’s and St Thomas’ collaborate to trial monkeypox lateral flow test

PDF Link Checker

SureScreen Diagnostics and Guy’s and St Thomas’ collaborate to trial monkeypox lateral flow test